PRILOCID 20 CAP is a highly effective formulation of Omeprazole 20 mg, a widely recognized proton pump inhibitor used in the management and treatment of various acid-peptic disorders. It is designed to reduce gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the surface of gastric parietal cells. This targeted action makes Omeprazole particularly useful in treating gastrointestinal conditions where acid control is crucial.

The therapeutic efficacy of PRILOCID 20 CAP lies in its ability to provide long-lasting acid suppression, thereby relieving symptoms associated with gastroesophageal reflux disease (GERD), healing erosive esophagitis, and promoting ulcer recovery. It is also indicated in cases of Helicobacter pylori-associated ulcers, where it is used in combination with appropriate antibiotics as part of eradication regimens. Additionally, PRILOCID 20 CAP plays a vital role in managing Zollinger-Ellison syndrome, a condition characterized by excessive gastric acid production.

Each PRILOCID 20 capsule delivers a consistent dose of Omeprazole in a delayed-release formulation to ensure the drug bypasses the acidic environment of the stomach and is absorbed in the small intestine. This mechanism improves bioavailability while protecting the active ingredient from degradation. The enteric-coated granules ensure optimal delivery of the drug at the desired site of action, ensuring a prolonged and consistent suppression of gastric acid for up to 24 hours.

PRILOCID 20 CAP is generally taken once daily before meals, preferably in the morning, to align with the circadian rhythm of gastric acid secretion. In cases of severe erosive esophagitis or Zollinger-Ellison syndrome, higher or divided doses may be administered under medical supervision. The formulation is well-tolerated in most patients and has a favorable safety profile. Common side effects include headache, nausea, abdominal discomfort, or constipation, while rare but serious adverse reactions such as vitamin B12 deficiency or hypomagnesemia may occur with prolonged use.

Omeprazole’s mechanism of action makes it especially effective in providing symptom relief from acid reflux, heartburn, and regurgitation. Moreover, its ulcer-healing properties make it a valuable therapeutic option in NSAID-induced gastric ulcers or stress-related mucosal damage in critically ill patients. PRILOCID 20 CAP has also demonstrated benefit as a prophylactic agent in patients at risk of gastrointestinal bleeding due to long-term NSAID or corticosteroid therapy.